← Evidence map

ReviewmAbs

CD19 as an attractive target for antibody-based therapy.

Ohad HammerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
trialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22820352